Oliver Brahmst | White & Case LLP International Law Firm, Global Law Practice
Oliver Brahmst
Oliver Brahmst

Oliver Brahmst

Partner, New York

Clients describe Oliver as a “partner of special skills for any transaction related project… one of the best lawyers you would want to have by your side during negotiations” and “a true legal counselor and excellent negotiator.”

Chambers USA

Overview

Oliver Brahmst is White & Case's Co-Global Head of Private Equity. His practice focuses on domestic and cross-border acquisitions and divestitures.

Oliver has built up a significant track record in the resolution of complex cross-border transactions, having worked on some of the most innovative and exciting deals of the last ten years.

Often working across multiple jurisdictions, Oliver has spearheaded the Firm's M&A Practice across the Americas, advising on high-profile transactions and taking a major role in such landmark deals as the representation of CVC Capital Partners in leading a consortium including Temasek Holdings and Vatera Healthcare Partners in their acquisition of a controlling stake in Alvogen, and in the representation of Nordic Capital and Avista Capital Partners' in their US$4.1 billion acquisition of the ConvaTec business unit from Bristol-Myers Squibb.

Oliver regularly leads the legal team in delivering innovative solutions to seemingly intractable challenges, such as his representation of Pilot Travel Centers during their acquisition of Flying J's core travel plaza and truck stop businesses. The deal took place at a critical point in Flying J's bankruptcy and, in the face of immense time constraints, Oliver and his colleagues created a framework for a transaction that simultaneously advanced Pilot Travel Centers' objectives and gained the support of the bankruptcy court and of Flying J's creditors' committee. The deal was described by The M&A Advisor (2011) as a "deal of the decade."

As a mark of the esteem in which he is held in the financial and legal community, Oliver is named as a leading individual for M&A in Chambers, Euromoney and The Legal 500.

Bars and Courts

  • New York State Bar

Education

  • LLM, Tax, Osgoode Hall Law School
  • LLB, University of Ottawa
  • BA, University of Toronto

Languages

  • English
  • German

Experience

HgCapital acquisition of a majority interest in Sovos Compliance, 2016

Oliver represented HgCapital, a European-based private equity firm, in its acquisition of a majority interest in Sovos Compliance, a leading provider of regulatory tax compliance software. He also advised in relation to a co-investment by Vista Equity Partners (the current majority interest holder in the Sovos Compliance Group) and the refinancing of the Sovos Compliance Group's existing debt package.

US$2.9 Billion Sale of Luxury Hotel Group to AccorHotels, 2015

Oliver represented FRHI Holdings Limited (FRHI), Qatar Investment Authority (QIA) and Kingdom Holding Company of Saudi Arabia on the US$2.9 billion stock-and-cash sale of FRHI, the parent company of luxury hotel brands Fairmont, Raffles and Swissôtel, to AccorHotels.

Hikma Pharmaceuticals PLC US$2.65 billion acquisition of generic drugs businesses, 2015

Oliver advised Hikma Pharmaceuticals PLC in its US$2.65 billion acquisition of the US-based generic drugs businesses, Roxane Laboratories and Boehringer Ingelheim Roxane, from German drug maker Boehringer Ingelheim.

CVC Capital Partners acquisition of a controlling stake in Alvogen, 2015

Oliver advised CVC Capital Partners in leading a consortium including Temasek Holdings and Vatera Healthcare Partners in their acquisition of a controlling stake in Alvogen, a leading generic pharmaceuticals company.

Salesforce acquisition of AKTA, 2015

Oliver represented Salesforce.com in its acquisition of AKTA US LLC., a leading mobile application development, design and consulting company.

GDF Suez's sale of power assets in Latin America, 2014

Oliver advised GDF Suez S.A., a French multinational energy company which operates in the fields of electricity generation and distribution, natural gas and renewables, regarding the US$840 million sale of power assets in Panama and Costa Rica to Celsia S.A. E.S.P., one of Colombia's largest power generators.

Electronic Funds Source's sale, 2014

Oliver represented Electronic Funds Source LLC, a leader in innovative corporate payment solutions, in its sale to an affiliate of Warburg Pincus by its existing equity holders, an investor group consisting of an affiliate of CVC Capital Partners and Pilot Travel Centers, First Data Transportation Services, Inc. and FJ Management Inc.

Univar's acquisitions of Magnablend Holdings and Basic Chemical Solutions, 2013 and 2010

Oliver acted for Univar Inc., a portfolio company of private equity firms CVC Capital Partners and Clayton Dubilier & Rice and a leading global distributor of industrial and specialty chemicals in more than 100 countries, in its acquisition of Magnablend Holdings, Inc., a custom chemical blending, manufacturing and packaging company, and in its acquisition of Basic Chemical Solutions, LLC, a leading global distributor and trader of commodity chemicals.

Pilot Flying J's acquisition of a controlling interest in Maxum Petroleum, 2012

Oliver advised Pilot Flying J, a portfolio company of private equity firm CVC Capital Partners and the largest owner and operator of travel centers in North America, on its acquisition of a controlling interest in Maxum Petroleum, Inc., a leading independent energy logistics company.

Harvest Partners, 2012 and 2010

Oliver advised on a large number of deals including the US$1.3 billion sale of Associated Materials, LLC to Hellman & Friedman LLC (the transaction was named LBO Exit of the Month in October 2010 by Dow Jones Private Equity) and in the acquisition of FCX Holdings Corp., a provider of process flow control solutions and products to a variety of process industries.

Pilot Travel Centers' acquisition of Flying J's core travel plaza and truck stop businesses, 2010

Oliver acted for Pilot Travel Centers in its acquisition of Flying J's core travel plaza and truck stop businesses. The acquisition, which combined the largest and second-largest travel plaza operators in the nation to create a new company called Pilot Flying J with a combined value in excess of US$5 billion, was featured as one of the Most Innovative M&A Transactions in the United States by The Financial Times (2010) and was named Deal of the Decade, Turnaround Deal of the Year (Large Market) and Divestiture Deal of the Year by The M&A Advisor (2011).

US$4.1 billion acquisition of the ConvaTec business unit, 2008

Oliver represented Nordic Capital and Avista Capital Partners in the US$4.1 billion acquisition of the ConvaTec business unit from Bristol-Myers Squibb. The transaction, the largest private equity deal globally at the time of signing in 2008, was named LBO Deal of the Year by Dow Jones' Private Equity Analyst.

Speaking Engagements

"What's Next in the World of Private Equity?", November 2014: 16th Annual Canadian Private Equity Summit,
Toronto
, (moderator)

"Mexico and Brazil Lead Deal-Making and Investments in Latin America", May 2013: Merrill Datasite Webinar,
New York
, (panelist)

"Analyzing Structural Trends in Cross-Border Deals", November 2012: 14th Annual Canadian Private Equity Summit,
Toronto
, (moderator)

"Private Equity in Emerging Markets: Trends and Key Success Factors", November 2011: 13th Annual Canadian Private Equity Summit,
Toronto
, (moderator)

Publications

  • Debt Financing Risk Allocation in US Sponsor-Led Acquisitions: A Short History and Primer, Euromoney's Banking Finance and Transactional Expert Guide, 2012 (co-author with Matthew Hendy)

Awards & Recognition

Listed for Private Equity Law and Leveraged Buyouts, Best Lawyers, 2016

Leading Individual for M&A and Private Equity, Chambers USA, 2016

Leading Individual for M&A and Private Equity, Chambers Global, 2016

Named "M&A Legal Advisor of the Year", M&A Advisor, 2015

Leading Individual for M&A and Private Equity in the United States, Euromoney's Banking Finance and Transactional Expert Guide, 2015